Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phillip Pang Insider Profile
11 Followers
Phillip Pang, EVP & Chief Medical Officer at Vir Biotechnology, holds 250.11K shares in Vir Biotechnology (Ticker: VIR). Most recently, Phillip Pang Sold $14,568 shares of Vir Biotechnology on Feb 26, 2024 for an estimated value of 146.26K.
Phillip Pang Vir Biotechnology (VIR)EVP & Chief Medical Officer
Vir Biotechnology (VIR)
EVP & Chief Medical Officer
Ranked #13,981 out of 98,042 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+32.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP & Chief Medical Officer
Roles that Phillip Pang holds in companies
Most Profitable Insider Trade
The most profitable trade made by Phillip Pang
Phillip Pang's Trading History
List of latest transactions for each holding click on a transaction to see Phillip Pang's performance on stock
You May Also Like
Phillip Pang insider profile FAQ
What is the percentage of profitable transactions made by Phillip Pang?
The percentage of profitable transactions made by Phillip Pang is 100%.
What is the average return per transaction made by Phillip Pang?
The average return per transaction made by Phillip Pang is 32.50%.
What stocks does Phillip Pang hold?
Phillip Pang holds: VIR stocks.
What was Phillip Pang’s latest transaction?
Phillip Pang latest transaction was an Informative Sell of $146.26K.
What was Phillip Pang's most profitable transaction?
Phillip Pang’s most profitable transaction was an Informative Sell of VIR stock on February 21, 2023. The return on the trade was 62.50%.
What is Phillip Pang's role in Vir Biotechnology?
Phillip Pang's role in Vir Biotechnology is EVP & Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.